For the safety of our patients and staff, we have updated our visitor policy, effective December 27. This includes important information about COVID-19 vaccination or testing for some visitors. Read the latest information for visitors.
MSK News Winter 2021/2022
Translational research at MSK is speeding up discoveries to help patients like Mark Denisiuk.
To Our MSK Community
Translational research takes knowledge gained in the lab and applies it to create new therapies for patients. Craig B. Thompson writes that MSK will be able to continue to drive a revolution in our understanding of cancer and improve our ability to prevent, diagnose, and treat the disease.
Translating Science Into Cures: Bringing Fresh Hope to the Denisiuk Family
Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.
Taking Aim at Pancreatic Cancer: Reasons to Be Optimistic
Pancreatic cancer will soon become the nation’s second leading cause of cancer death, but there is reason for optimism. Vinod Balachandran is leading a clinical trial testing whether mRNA vaccines can prevent pancreatic cancer from returning after surgery.